167
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Clinical characteristics of reflux esophagitis among patients with liver cirrhosis: a case-control study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 384-391 | Received 27 Oct 2021, Accepted 08 Dec 2021, Published online: 29 Dec 2021

References

  • Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–440.
  • Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda Study Report. Scand J Gastroenterol. 2005;40(3):275–285.
  • Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57(10):1354–1359.
  • Zou D, He J, Ma X, et al. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC). Scand J Gastroenterol. 2011;46(2):133–141.
  • Peng S, Cui Y, Xiao YL, et al. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Endoscopy. 2009;41(12):1011–1017.
  • Fakhre Yaseri H. Gender is a risk factor in patients with gastroesophageal reflux disease. Med J Islam Repub Iran. 2017;31:58.
  • Kim YS, Kim N, Kim GH. Sex and gender differences in gastroesophageal reflux disease. J Neurogastroenterol Motil. 2016;22(4):575–588.
  • Li B, Zhang B, Ma JW, et al. High prevalence of reflux esophagitis among upper endoscopies in Chinese patients with chronic liver diseases. BMC Gastroenterol. 2010;10(1):54.
  • Zhang J, Cui PL, Lv D, et al. Gastroesophageal reflux in cirrhotic patients without esophageal varices. World J Gasteroenterol. 2011;17(13):1753–1758.
  • Theocharidou E, Dhar A, Patch D. Gastrointestinal motility disorders and their clinical implications in cirrhosis. Gastroenterol Res Pract. 2017;2017:8270310.
  • Chen SM, Lo GH, Lai KH, et al. Influence of endoscopic variceal ligation on oesophageal motility. J Gastroenterol Hepatol. 2002;14(3):231–235.
  • Navarro-Rodriguez T, Hashimoto CL, Carrilho FJ, et al. Reduction of abdominal pressure in patients with ascites reduces gastroesophageal reflux. Dis Esophagus. 2003;16(2):77–82.
  • Hsu CS, Wang CC, Wang PC, et al. Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection. Hepatol Int. 2010;4(3):585–593.
  • Ghoshal UC, Saraswat VA, Aggarwal R, et al. Oesophageal motility and gastro-oesophageal reflux: effect of variceal eradication by endoscopic sclerotherapy. J Gastroenterol Hepatol. 1998;13(10):1033–1038.
  • Tao J, Li J, Chen X, et al. Endoscopic variceal sequential ligation does not increase risk of gastroesophageal reflux disease in cirrhosis patients. Dig Dis Sci. 2020;65(1):329–335.
  • Koya Y, Shibata M, Watanabe T, et al. Influence of gastroesophageal flap valve on esophageal variceal bleeding in patients with liver cirrhosis. Dig Endosc. 2021;33(1):100–109.
  • Costa ND, Cadiot G, Merle C, et al. Bleeding reflux esophagitis: a prospective 1-year study in a university hospital. Am J Gastroenterol. 2001;96(1):47–51.
  • Suzuki K, Suzuki K, Koizumi K, et al. Effect of symptomatic gastroesophageal reflux disease on quality of life of patients with chronic liver disease. Hepatol Res. 2008;38(4):335–339.
  • Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111(1):85–92.
  • [Chinese guidelines on the management of liver cirrhosis]. Zhonghua Gan Zang Bing Za Zhi. 2019;27(11):846–865.
  • Fraser AG, Pounder RE, Burroughs AK. Gastric secretion and peptic ulceration in cirrhosis. J Hepatol. 1993;19(1):171–182.
  • Lamps LW, Hunt CM, Green A, et al. Alterations in colonic mucosal vessels in patients with cirrhosis and noncirrhotic portal hypertension. Hum Pathol. 1998;29(5):527–535.
  • Gresele P, Momi S, Guglielmini G. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. Biochem Pharmacol. 2019;166:300–312.
  • Murray JA, Ledlow A, Launspach J, et al. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology. 1995;109(4):1241–1248.
  • Liu B, Liu X, Tang C, et al. Esophageal dysmotility and the change of synthesis of nitric oxide in a feline esophagitis model. Dis Esophagus. 2002;15(3):193–198.
  • Ishiyama F, Iijima K, Asanuma K, et al. Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats. Scand J Gastroenterol. 2009;44(5):527–537.
  • Fass R, Landau O, Kovacs TO, et al. Esophageal motility abnormalities in cirrhotic patients before and after endoscopic variceal treatment. Am J Gastroenterol. 1997;92(6):941–946.
  • Bretagne JF, Gosselin A, Le Jean-Colin I, et al. Morphology and function of the esophagus after sclerotherapy of esophageal varices in cirrhotic patients. Gastroenterol Clin Biol. 1987;11(1):48–55.
  • Sauerbruch T, Wirsching R, Leisner B, et al. Esophageal function after sclerotherapy of bleeding varices. Scand J Gastroenterol. 1982;17(6):745–751.
  • Schechter RB, Lemme EM, Coelho HS. Gastroesophageal reflux in cirrhotic patients with esophageal varices without endoscopic treatment. Arq Gastroenterol. 2007;44(2):145–150.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.